Skip to main content

Beam Therapeutics Inc.

BEAM
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001745999

In the last 90 days, Beam Therapeutics Inc. insiders filed 0 open-market purchases and 2 sales; 277 institutions reported holding it in 13F filings for Q2 2026, worth $3.75B in total; superinvestors ARK Invest and Duquesne Family Office hold it.

Q1 2024 vs. Q4 2023

How the institutions holding Beam Therapeutics Inc. changed between Q4 2023 and Q1 2024.

All holders in Q1 2024All holders in Q4 2023

13F holders of BEAM: Q4 2023 compared with Q1 2024
MeasureQ4 2023Of which not filed for Q1 2024Q1 2024Change
Holders1851221+37
Shares68.9M1.10K70.3M+1.41M (+2.1%)
Value$1.88B$30.1K$2.32B+$447.0M (+23.8%)

1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (55)

Institutions that held Beam Therapeutics Inc. at the end of Q1 2024 but not at the end of Q4 2023.

Institutions new to BEAM in Q1 2024
InstitutionSharesValue% of portfolio
Darwin Global Management, Ltd.2,119,598$70.0M9.32%
Two Sigma Investments, LP358,798$11.9M0.03%
TD Asset Management Inc162,692$5.38M0.01%
Two Sigma Advisers, LP148,200$4.90M0.01%
Qube Research & Technologies Ltd98,055$3.24M0.01%
Walleye Capital LLC97,737$3.23M0.04%
PDT Partners, LLC55,649$1.84M0.17%
Point72 Hong Kong Ltd48,325$1.60M0.08%
Tudor Investment Corp Et Al47,845$1.58M0.02%
Twinbeech Capital LP34,641$1.14M0.02%
Bamco Inc30,000$991.2K0.00%
Virtu Financial LLC26,486$875.0K0.07%
Capula Management Ltd18,853$622.9K0.02%
Point72 (DIFC) Ltd18,622$615.3K0.05%
Capital Fund Management S.A.16,189$534.9K0.01%
Teza Capital Management LLC16,102$532.0K0.07%
Point72 Asia (Singapore) Pte. Ltd.15,496$512.0K0.13%
Pearl River Capital, LLC15,429$509.8K0.08%
Gotham Asset Management, LLC14,932$493.4K0.01%
Creative Planning12,061$398.5K0.00%
Commonwealth Equity Services, LLC11,864$392.0K0.00%
New York Life Investment Management LLC10,734$354.7K0.00%
Fishman Jay A Ltd10,000$330.4K0.04%
Bayesian Capital Management, LP8,803$290.9K0.03%
ExodusPoint Capital Management, LP8,475$280.0K0.00%
Aquatic Capital Management LLC7,900$261.0K0.01%
Verition Fund Management LLC7,894$260.8K0.00%
JustInvest LLC7,630$252.1K0.01%
Stifel Financial Corp7,626$252.0K0.00%
Steel Peak Wealth Management LLC7,505$248.0K0.01%
DLK Investment Management, LLC7,225$238.7K0.10%
Thrive Wealth Management, LLC6,925$228.8K0.05%
AQR Capital Management LLC6,524$215.6K0.00%
McGuire Investment Group, LLC6,250$206.5K0.03%
Reynders McVeigh Capital Management, LLC6,055$201.0K0.01%
Quest Partners LLC4,953$163.6K0.03%
Quantbot Technologies LP2,800$92.5K0.01%
Group One Trading, L.P.2,453$81.0K0.00%
WR Wealth Planners, LLC1,500$49.6K0.02%
STRS Ohio1,500$49.0K0.00%
Catalyst Funds Management Pty Ltd1,300$43.0K0.01%
Sandy Spring Bank1,200$39.6K0.00%
Pacer Advisors, Inc.1,134$37.5K0.00%
Quarry LP800$26.4K0.01%
Riverview Trust Co796$26.3K0.02%
Trust Co of Vermont200$6.61K0.00%
RFP Financial Group LLC170$5.62K0.00%
CIBC Private Wealth Group, LLC150$4.90K0.00%
Raleigh Capital Management Inc.100$3.30K0.00%
Macroview Investment Management LLC80$2.64K0.00%
EverSource Wealth Advisors, LLC48$1.02K0.00%
Gen-Wealth Partners Inc18$5950.00%
Smartleaf Asset Management LLC15$5090.00%
Nelson, Van Denburg & Campbell Wealth Management Group, LLC14$4620.00%
Rothschild Investment LLC5$1650.00%

Sold out (18)

Institutions that held Beam Therapeutics Inc. at the end of Q4 2023 and filed for Q1 2024 without it.

Not filed for Q1 2024 yet (1)

Institutions that held Beam Therapeutics Inc. at the end of Q4 2023 and haven't filed a 13F for Q1 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding BEAM in Q4 2023 that haven't filed for Q1 2024
InstitutionShares, Q4 2023Value, Q4 2023
Fairfield Financial Advisors, LTD1,105$30.1K